Biomarkers measured in this study at baseline included: ST2 (fibrosis); GDF-15 (apoptosis); NT-proBNP (myocyte stretch); cTnI (myocardial injury); hsCRP and IL-6 (inflammation); Cystatin C (renal dysfunction); and D-dimer (thrombosis).13 (link)-18 (link) GDF-15, Cystatin C, and IL-6 were measured using a Quantikine Human Immunoassay (R&D systems, Minneapolis, MN). ST2 was measured using the Presage Assay (Critical Diagnostics, San Diego, CA). CRP was measured using the CardioPhase High Sensitivity C-Reactive Protein Immunoassay (Siemens Medical Solutions Diagnostics, Tarrytown, NY). Troponin was measured using the Advia Centaur TnI-Ultra Assay (Siemens Medical Solutions Diagnostics, Tarrytown, NY). NT-proBNP was measured by the Roche E Modular assay (Roche Diagnostics Corporation, Indianapolis, IN). D-dimer was measured using the Zymutest D-Dimer ELISA (Aniara, West Chester, Ohio). Details regarding sensitivity, range, and coefficients of variation have been published previously2 (link).